Acute Pain Management in Patients on Opioid Replacement Therapy
Status:
Active, not recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This is an outpatient randomized within subject placebo-controlled human laboratory
investigation of analgesia (as assessed with quantitative sensory testing; QST) from ketamine
alone and in combination with hydromorphone in buprenorphine maintained participants. The
goals of this project are to characterize the analgesic, subjective, and physiologic effects
of ketamine combined with hydromorphone in patients on buprenorphine maintenance for opioid
use disorder.